Cantitate/Preț
Produs
Total produse
Vezi coșul
Platinum-Based Drugs in Cancer Therapy de Lloyd R. Kelland

Platinum-Based Drugs in Cancer Therapy: Cancer Drug Discovery and Development

Editat de Lloyd R. Kelland, Nicholas P. Farrell
en Limba Engleză Hardback – 24 mar 2000
Leading international experts comprehensively review all aspects of platinum anticancer drugs and their current use in treatment, as well as examining their future therapeutic prospects. Writing from a variety of disciplines, these authorities discuss the chemistry of cisplatin in aqueous solution, the molecular interaction of platinum drugs with DNA, and such exciting new areas as DNA mismatch repair and replicative bypass, apoptosis, and the transport of platinum drugs into tumor cells. The emergent platinum drugs of the future-orally active agents, the sterically hindered ZD0473, and the polynuclear charged platinum BBR3464-are also fully considered. Timely and interdisciplinary, Platinum-Based Drugs in Cancer Therapy offers cancer therapeutics specialists an illuminating survey of every aspect of platinum drugs from mechanisms of action to toxicology, tumor resistance, and new analogs.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 75971 lei  6-8 săpt.
  Humana Press Inc. – 8 dec 2010 75971 lei  6-8 săpt.
Hardback (1) 107423 lei  6-8 săpt.
  Humana Press Inc. – 24 mar 2000 107423 lei  6-8 săpt.

Din seria Cancer Drug Discovery and Development

  • 5% CNS Cancer: Models, Markers, Prognostic Factors, Targets, and Therapeutic Approaches
    Preț: 143261 lei
  • 5% Developments in T Cell Based Cancer Immunotherapies
    Preț: 107654 lei
  • 5% mTOR Pathway and mTOR Inhibitors in Cancer Therapy
    Preț: 137506 lei
  • 5% Antiangiogenic Agents in Cancer Therapy
    Preț: 137017 lei
  • 5% Tumor Models in Cancer Research
    Preț: 141057 lei
  • 5% Telomeres and Telomerase in Cancer
    Preț: 131671 lei
  • 5% Gene Therapy for Cancer
    Preț: 139816 lei
  • 5% Proteasome Inhibitors in Cancer Therapy
    Preț: 108166 lei
  • 5% Oncogene-Directed Therapies
    Preț: 109393 lei
  • 24% Protein Tyrosine Kinases: From Inhibitors to Useful Drugs
    Preț: 103758 lei
  • 5% Cancer Chemoprevention: Volume 2: Strategies for Cancer Chemoprevention
    Preț: 142423 lei
  • 5% Apoptosis, Senescence and Cancer
    Preț: 135076 lei
  • 5% Bioinformatics in Cancer and Cancer Therapy
    Preț: 137682 lei
  • 5% Bone Metastasis
    Preț: 108151 lei
  • 5% Nitric Oxide (NO) and Cancer: Prognosis, Prevention, and Therapy
    Preț: 138752 lei
  • 5% Tumor Suppressor Genes in Human Cancer
    Preț: 138873 lei
  • 5% Platinum-Based Drugs in Cancer Therapy
    Preț: 75971 lei
  • 5% Regional Cancer Therapy
    Preț: 139727 lei
  • 5% Checkpoint Controls and Targets in Cancer Therapy
    Preț: 107844 lei
  • 5% Antifolate Drugs in Cancer Therapy
    Preț: 139319 lei
  • 5% Transforming Growth Factor-Beta in Cancer Therapy, Volume II: Cancer Treatment and Therapy
    Preț: 136580 lei
  • 5% Transforming Growth Factor-Beta in Cancer Therapy, Volume I: Basic and Clinical Biology
    Preț: 141911 lei
  • 5% Farnesyltransferase Inhibitors in Cancer Therapy
    Preț: 107508 lei
  • 5% Supportive Care in Cancer Therapy
    Preț: 98217 lei
  • 5% Nucleic Acid Therapeutics in Cancer
    Preț: 70697 lei
  • 5% Stem Cells and Cancer
    Preț: 133174 lei
  • 5% EGFR Signaling Networks in Cancer Therapy
    Preț: 129738 lei
  • 5% Hematopoietic Growth Factors in Oncology: Basic Science and Clinical Therapeutics
    Preț: 109233 lei
  • 5% Sensitization of Cancer Cells for Chemo/Immuno/Radio-therapy
    Preț: 139193 lei
  • 5% Hormone Therapy in Breast and Prostate Cancer
    Preț: 107900 lei
  • 5% Platinum and Other Heavy Metal Compounds in Cancer Chemotherapy: Molecular Mechanisms and Clinical Applications
    Preț: 131774 lei
  • 5% The Oncogenomics Handbook
    Preț: 142282 lei
  • 5% Macromolecular Anticancer Therapeutics
    Preț: 188387 lei
  • 5% Histone Deacetylases: Transcriptional Regulation and Other Cellular Functions
    Preț: 137773 lei
  • 5% Cancer Drug Resistance
    Preț: 139761 lei
  • 5% Matrix Metalloproteinase Inhibitors in Cancer Therapy
    Preț: 106870 lei
  • 5% Fluoropyrimidines in Cancer Therapy
    Preț: 107810 lei
  • 5% In Vivo Imaging of Cancer Therapy
    Preț: 99056 lei
  • 5% The Tumor Microenvironment
    Preț: 140168 lei
  • 5% Camptothecins in Cancer Therapy
    Preț: 138787 lei
  • 5% Targets for Cancer Chemotherapy: Transcription Factors and Other Nuclear Proteins
    Preț: 76502 lei
  • 5% Cancer Proteomics: From Bench to Bedside
    Preț: 131170 lei
  • 5% Genomics and Pharmacogenomics in Anticancer Drug Development and Clinical Response
    Preț: 133174 lei
  • 5% COX-2 Blockade in Cancer Prevention and Therapy
    Preț: 108116 lei
  • 5% Cytokines in the Genesis and Treatment of Cancer
    Preț: 139938 lei

Preț: 107423 lei

Preț vechi: 113078 lei
-5% Nou

Puncte Express: 1611
Preț estimativ în valută:
20558€ • 21626$ • 17154£

Carte tipărită la comandă

Livrare economică 09-23 ianuarie 25

 Adaugă în coș

Wish list
Gift list
Am citit!
Adaugă în listă
Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9780896035997
ISBN-10: 0896035999
Pagini: 341
Ilustrații: XII, 341 p. 5 illus.
Dimensiuni: 155 x 235 x 27 mm
Greutate: 0.71 kg
Ediția:2000
Editura: Humana Press Inc.
Colecția Humana
Seria Cancer Drug Discovery and Development

Locul publicării:Totowa, NJ, United States

Public țintă

Research

Cuprins

I: Platinum Chemistry.- 1 The Chemistry of Cisplatin in Aqueous Solution.- 2 Chemistry and Structural Biology of 1,2-Interstrand Adducts of Cisplatin.- 3 Transplatin-Modified Oligonucleotides as Potential Antitumor Drugs.- II: Platinum Biochemistry.- 4 Cisplatin Accumulation.- 5 Cisplatin Resistance in Ovarian Cancer: Mismatch Repairand Engagement of Apoptosis.- 6 DNA Adduct Tolerance and Bypass.- 7 How Does Cisplatin Kill Cells?.- III: Clinical Antitumor Activity and Toxicology of Platinum Drugs.- 8 Clinical Experience with Cisplatin and Carboplatin.- 9 Clinical Experience: Platinum and Taxanes.- 10 Clinical Experience: DACH-Based Platinum Drugs.- 11 Clinical Toxicology of Platinum-Based Cancer Chemotherapeutic Agents.- 12 Toxicology and Regulatory Aspects of Platinum Drugs.- IV: New Platinum Drugs of the Future.- 13 New Platinum Drugs: The Pathway to Oral Therapy.- 14 Polynuclear Charged Platinum Compounds as a New Class of Anticancer Agents: Toward a New Paradigm.

Recenzii

This volume of the Cancer Drug Discovery and Development series provides comprehensive coverage of some of the basic science associated with cisplatin, its interaction with DNA and how recognitions and processing of platinum-DNA adducts may be associated with tumour response or resistance. ...Bringing together the most recent research in the area of platinum drugs...The editors of this book have produced a collection of articles which will be of interest to those who need an introduction to the field of platinum drugs. For anyone already familiar with the field, the chapters on the newer analogues and on some of the more recent basic molecular pharmacology issues will provide a useful update. -The Lancet

"The great attention is also paid to all toxicological aspects of platinum drugs from both clinical and regulatory perspective.... The Platinum-based Drugs in Cancer Therapy appears to be a comprehensive book useful for scientist, medical oncologist and pharmacist seeking answer on specific questions concerning preclinical and clinical data of platinum drugs."-Neoplasma

"The strength of the text lies in the diversity of topics that are covered in such a succinct fashion. Clinicians will benefit from the earlier focus on basic chemistry and biochemistry, while the bench scientist will better appreciate the practicalities of using these compounds from the lucid experiences of the clinical case studies."-Journal of Medicinal Chemistry

"This is a useful reference book for scientists and practitioners who have a focus or interest in the chemistry and biochemistry of the platinum compounds. Oncologists will find it helpful for its summary of applications of cisplatin and carboplatin, especially in combination with paclitaxel."--Oncology Journal, November, 2000

"...the book should find its place in the library of many laboratories involved mainly in preclinical oncological research."-Annals of Oncology

"This new bookby Kelland and Farrell is a well-constructed and authoritative account of current knowledge concerning the pharmacology and clinical application of platinum anticancer drugs. It is well illustrated with clear diagrams and appropriate data. ...Not only do platinum agents remain a key component of current cancer therapy for the majority of common solid tumours but recent advances have demonstrated the scope for expansion of the clinical spectrum of activity, the ability to overcome resistance, and the potential introduction of oral delivery." - Clinical Oncology

Textul de pe ultima copertă

In Platinum-Based Drugs in Cancer Therapy, leading international experts comprehensively review all aspects of platinum anticancer drugs and their current use in treatment, as well as examining their future therapeutic prospects. Writing from a variety of disciplines, these authorities discuss the chemistry of cisplatin in aqueous solution, the molecular interaction of platinum drugs with DNA, and such exciting new areas as DNA mismatch repair, replicative bypass, apoptosis, and the transport of platinum drugs into tumor cells. The antitumor activity and toxicology of platinum-based drugs is also addressed in a thorough discussion of the clinical experience with cisplatin and carboplatin, including their promising recent combinations with taxanes and oxaliplatin. The emergent platinum drugs of the future-orally active agents, the sterically hindered ZD0473, and the polynuclear charged platinum BBR3464-are also fully considered.
Timely and interdisciplinary, Platinum-Based Drugs in Cancer Therapy offers cancer therapeutics specialists an illuminating survey of every aspect of platinum drugs from mechanisms of action to toxicology, tumor resistance, and new analogs. This important book captures the essence of the fresh clinical possibilities now strongly emerging thirty years after cisplatin's discovery.

Caracteristici

Includes supplementary material: sn.pub/extras